AAAAAA
Results:
1-13
|
Results: 13
Authors:
Kraiczy, P
Skerka, C
Kirschfink, M
Zipfel, PF
Brade, V
Citation: P. Kraiczy et al., Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates, INT IMMUNO, 1(3), 2001, pp. 393-401
Authors:
Hunfeld, KP
Weigand, J
Wichelhaus, TA
Kekoukh, E
Kraiczy, P
Brade, V
Citation: Kp. Hunfeld et al., In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi, INT J ANT A, 17(3), 2001, pp. 203-208
Authors:
Wichelhaus, TA
Hunfeld, KP
Boddinghaus, B
Kraiczy, P
Schafer, V
Brade, V
Citation: Ta. Wichelhaus et al., Rapid molecular typing of methicillin resistant Staphylococcus aureus by PCR-RFLP, INFECT CONT, 22(5), 2001, pp. 294-298
Authors:
Hunfeld, KP
Wichelhaus, TA
Kekoukh, E
Molitor, M
Kraiczy, P
Brade, V
Citation: Kp. Hunfeld et al., In vitro susceptibility of the Borrelia burgdorferi sensu lato complex to ABT-773, a novel ketolide, J ANTIMICRO, 48(3), 2001, pp. 447-449
Authors:
Kraiczy, P
Weigand, J
Wichelhaus, TA
Heisig, P
Backes, H
Schafer, V
Acker, G
Brade, V
Hunfeld, KP
Citation: P. Kraiczy et al., In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi, ANTIM AG CH, 45(9), 2001, pp. 2486-2494
Authors:
Kraiczy, P
Skerka, C
Brade, V
Zipfel, PF
Citation: P. Kraiczy et al., Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi, INFEC IMMUN, 69(12), 2001, pp. 7800-7809
Authors:
Kraiczy, P
Skerka, C
Kirschfink, M
Brade, V
Zipfel, PF
Citation: P. Kraiczy et al., Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H, EUR J IMMUN, 31(6), 2001, pp. 1674-1684
Authors:
Hunfeld, KP
Kraiczy, P
Wichelhaus, TA
Schafer, V
Brade, V
Citation: Kp. Hunfeld et al., New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances, EUR J CL M, 19(1), 2000, pp. 27-32
Authors:
Hunfeld, KP
Kraiczy, P
Wichelhaus, TA
Schafer, V
Brade, V
Citation: Kp. Hunfeld et al., Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates, INT J ANT A, 15(1), 2000, pp. 11-17
Authors:
Kraiczy, P
Hunfeld, KP
Breitner-Ruddock, S
Wurzner, R
Acker, G
Brade, V
Citation: P. Kraiczy et al., Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates, IMMUNOBIOL, 201(3-4), 2000, pp. 406-419
Authors:
Kraiczy, P
Hunfeld, KP
Peters, S
Wurzner, R
Acker, G
Wilske, B
Brade, V
Citation: P. Kraiczy et al., Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant, J MED MICRO, 49(10), 2000, pp. 917-928
Authors:
Kraiczy, P
Peters, S
Seitz, C
Wurzner, R
Oschmann, P
Brade, V
Citation: P. Kraiczy et al., Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B-burgdorferi strains, WIEN KLIN W, 110(24), 1998, pp. 886-893
Authors:
Hunfeld, KP
Allwinn, R
Peters, S
Kraiczy, P
Brade, V
Citation: Kp. Hunfeld et al., Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany, WIEN KLIN W, 110(24), 1998, pp. 901-908
Risultati:
1-13
|